home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
Post navigation
Previous Post
Previous
Fierce Biotech Names Boundless Bio a “Fierce 15” Biotech Company of 2023
Next Post
Next
Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference